Resources

This retrospective look at 2014 focuses on a few actions taken by regulators that have high impact to the pharmaceutical industry. It is not meant to be an all-encompassing analysis of actions taken in 2014. The actions we choose to address for 2014 are: Total FDA drug GMP warning letters were essentially flat in FY […]

Here are the featured FDA 483s for the week. You can obtain these at the FDAzilla 483s store here>> 6/4/2014 Medrite Supply Inc. Walnut Creek CA United States 5/15/2014 Medtronic Vascular Galway Limited Galway Ireland 1/18/2013 Michael M. Dao, M.D. Garden Grove CA United States 5/16/2014 Micro Power Electronics, Inc. dba Electrochem Solutions, Inc Beaverton […]

Here are the featured FDA 483s for the week. You can obtain these at the FDAzilla 483s store here>> 5/21/2014 Inoveon Corporation Oklahoma City OK United States 1/18/2013 Jerzy Windyga, MD, PhD Warsaw Poland 11/1/2013 Kong Teng TAN, M.D. Toronto Canada 5/10/2014 KORR Medical Technologies, Inc. Salt Lake City UT United States 6/25/2014 Life Sensing […]

I thought I’d share with you a few things that we believe will impact us immensely. They impact us because they impact you. 1. FDA inspectionsareundergoing a massive change. In 2015, approximately60% of inspections will happen overseas, and this trend will likely continue. Over time, I’d expect the FDA to eventually balance inspections based on […]

Here are the featured FDA 483s for the week. You can obtain these at the FDAzilla 483s store here>> 5/1/2014 Cardinal Health 414 LLC Colton CA United States 6/17/2014 Cardinal Health 418, Inc. Aurora CO United States 6/20/2014 CareFusion 2200, Inc. Mannford OK United States 5/20/2014 CaridianBCT, Inc. Lakewood CO United States 6/25/2014 Cascade Medical […]

Yesterday was Part I. Today, we get to hear a little more from Barb on her background. What publicly available information do you depend on for your job? How do you use that information? I focus primarily on the US, EU, ICH and PIC/S. For laws, regulations and guidance the regulator specific websites publish information […]

Barbara Unger: I see four trends in drug GMP enforcement actions over the past couple of years and all reinforce FDA’s focus on patient safety and public health. The most visible trend for fiscal year 2014 warning letter enforcement actions was the focus on compounding pharmacies. These businesses received the majority of GMP warning letters […]

Is part of your job to prep your company for FDA inspections? Do you spend part of your week culling through various FDA, EMA, ICH, PIC/S and EMA-related websites tracking down changes in regulations, guidelines, and concept papers? Is the FDA ORA reading room bookmarked on your browser? If so, we are excited to […]

Sometimes we get emails from people who are just starting out in the field of regulatory, quality, and compliance, asking us – what advice do we havefor new people to get onto the right path? I turned to you on LinkedIn, and these are some of my favorite responses: It basically comes down to this.., […]

Here are the featured FDA 483s for the week. You can obtain these at the FDAzilla 483s store here>> Inspection End Date Company City/Local State/Region Country 3/15/13 Paragon Research Center San Antonio TX United States 7/7/11 Patheon Inc. Whitby Canada 4/6/12 Peptido GmbH Bexbach Germany 2/27/13 Philips Burton Franklin Park IL United States 12/18/13 PureTek […]